Compass Therapeutics, Inc. (CMPX) — Dilution Risk Analysis
Current Snapshot
Compass Therapeutics, Inc. (CMPX) has a DilutionWatch score of 38/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 38/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 6, SC 13G/A 1, SC 13G 1, EFFECT 1, 3 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-10-02 | 0001171843-26-006349 |
| 4 | 2026-09-25 | 0001171843-26-006235 |
| SC 13G/A | 2026-08-14 | 0001213900-26-089989 |
| SC 13G | 2026-08-07 | 0000093751-26-000440 |
| 4 | 2026-04-29 | 0001171843-26-002834 |
| 4 | 2026-04-29 | 0001171843-26-002840 |
| 4 | 2026-02-10 | 0001171843-26-000722 |
| 4 | 2026-01-12 | 0001171843-26-000205 |
| EFFECT | 2026-01-07 | 9999999995-26-000102 |
| 3 | 2026-01-05 | 0001171843-26-000049 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $400,000,000 | Source |
| Cash runway | 38 months | Source |
| Three-year share count growth | 41.26% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 38/10) Source
- Cash Runway
- 38 months Source
- Shelf Registration Capacity
- $400,000,000 Source
- Share Count Growth (3-Year)
- 41.26% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.